The role of raltegravir in the treatment of HIV-2 infections: evidence from a case series

K. Peterson, J. Ruelle, M. Vekemans, F.P. Siegal, J.R. Deayton, R. Colebunders

Research output: Contribution to journalA1: Web of Science-article

Abstract

We describe five patients with HIV-2 infection (four antiretroviral-experienced and one antiretroviral-naive) treated with a regimen containing raltegravir. All responded to treatment as demonstrated by viral load and CD4(+) T-cell count monitoring. Our series confirms the clinical effectiveness of raltegravir in HIV-2-infected patients when given with other antiretrovirals to which the virus is susceptible.
Original languageEnglish
JournalAntiviral Therapy
Volume17
Issue number6
Pages (from-to)1097-1100
Number of pages4
ISSN1359-6535
DOIs
Publication statusPublished - 2012

Keywords

  • Viral diseases
  • HIV-2
  • AIDS
  • Case reports
  • HAART
  • Antiretrovirals
  • Raltegravir
  • Viral load
  • CD4 lymphocyte count
  • Treatment outcome
  • Effectiveness
  • Monitoring

Fingerprint Dive into the research topics of 'The role of raltegravir in the treatment of HIV-2 infections: evidence from a case series'. Together they form a unique fingerprint.

Cite this